JP2013501091A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013501091A5 JP2013501091A5 JP2012522921A JP2012522921A JP2013501091A5 JP 2013501091 A5 JP2013501091 A5 JP 2013501091A5 JP 2012522921 A JP2012522921 A JP 2012522921A JP 2012522921 A JP2012522921 A JP 2012522921A JP 2013501091 A5 JP2013501091 A5 JP 2013501091A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogel
- hyaluronic acid
- thiol
- item
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 28
- 229920002674 hyaluronan Polymers 0.000 claims description 27
- 229960003160 hyaluronic acid Drugs 0.000 claims description 27
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 150000003573 thiols Chemical class 0.000 claims description 18
- -1 2- (vinylsulfonyl) ethoxy Chemical group 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 239000004971 Cross linker Substances 0.000 claims description 8
- 239000003246 corticosteroid Substances 0.000 claims description 8
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000012867 bioactive agent Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 208000038016 acute inflammation Diseases 0.000 claims description 4
- 230000006022 acute inflammation Effects 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 4
- 210000000845 cartilage Anatomy 0.000 claims description 4
- 208000037976 chronic inflammation Diseases 0.000 claims description 4
- 230000006020 chronic inflammation Effects 0.000 claims description 4
- 150000004662 dithiols Chemical class 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 4
- 210000004872 soft tissue Anatomy 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 claims description 4
- 210000000515 tooth Anatomy 0.000 claims description 4
- 229960002117 triamcinolone acetonide Drugs 0.000 claims description 4
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims description 4
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 125000000600 disaccharide group Chemical group 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- CYVOBUFEWWAPJJ-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol;2-ethyl-2-(hydroxymethyl)propane-1,3-diol Chemical compound CCC(CO)(CO)CO.OCC(O)COCC(O)CO CYVOBUFEWWAPJJ-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 150000002314 glycerols Chemical class 0.000 claims description 2
- 238000002513 implantation Methods 0.000 claims description 2
- 230000002757 inflammatory effect Effects 0.000 claims description 2
- 201000008482 osteoarthritis Diseases 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 229960005294 triamcinolone Drugs 0.000 claims 2
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- TZIZWYVVGLXXFV-FLRHRWPCSA-N Triamcinolone hexacetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@@H]2O TZIZWYVVGLXXFV-FLRHRWPCSA-N 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229950006782 triamcinolone benetonide Drugs 0.000 claims 1
- GUYPYYARYIIWJZ-CYEPYHPTSA-N triamcinolone benetonide Chemical compound O=C([C@]12[C@H](OC(C)(C)O1)C[C@@H]1[C@@]2(C[C@H](O)[C@]2(F)[C@@]3(C)C=CC(=O)C=C3CC[C@H]21)C)COC(=O)C(C)CNC(=O)C1=CC=CC=C1 GUYPYYARYIIWJZ-CYEPYHPTSA-N 0.000 claims 1
- 229960004221 triamcinolone hexacetonide Drugs 0.000 claims 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23007409P | 2009-07-30 | 2009-07-30 | |
| US61/230,074 | 2009-07-30 | ||
| US31195310P | 2010-03-09 | 2010-03-09 | |
| US61/311,953 | 2010-03-09 | ||
| PCT/US2010/043108 WO2011014432A1 (en) | 2009-07-30 | 2010-07-23 | Modified hyaluronic acid polymer compositions and related methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013501091A JP2013501091A (ja) | 2013-01-10 |
| JP2013501091A5 true JP2013501091A5 (cg-RX-API-DMAC7.html) | 2013-07-04 |
| JP5683587B2 JP5683587B2 (ja) | 2015-03-11 |
Family
ID=42932126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012522921A Expired - Fee Related JP5683587B2 (ja) | 2009-07-30 | 2010-07-23 | 修飾ヒアルロン酸ポリマー組成物および関連する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US7829118B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2459239A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5683587B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101551681B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102573941B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010276574B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012002117A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2769470A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2012000243A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL217750B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012001204A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2539395C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG178146A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011014432A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201200727B (cg-RX-API-DMAC7.html) |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012002117A2 (pt) | 2009-07-30 | 2019-09-24 | Carbylan Biosurgery Inc | composições poliméricas modificadas de ácido hialurônico e métodos relacionados. |
| CZ2009836A3 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace |
| CZ302503B6 (cs) | 2009-12-11 | 2011-06-22 | Contipro C A.S. | Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace |
| CA2805008C (en) * | 2010-07-12 | 2015-05-12 | Shin Poong Pharmaceutical Co., Ltd. | Filler composition for tissue augmentation comprising a hydrogel of hyaluronic acid cross-linked with alkylene diamine |
| FR2968306B1 (fr) * | 2010-12-06 | 2014-02-28 | Teoxane | Procede de preparation d'un gel reticule |
| US20120142628A1 (en) * | 2010-12-07 | 2012-06-07 | Allergan, Inc. | Methods for treating crepitus |
| GB201101429D0 (en) * | 2011-01-27 | 2011-03-16 | Biocompatibles Uk Ltd | Drug delivery system |
| DK2699274T3 (en) * | 2011-04-20 | 2015-06-15 | Carbylan Therapeutics Inc | In situ gelling formations |
| CZ304072B6 (cs) * | 2011-04-26 | 2013-09-25 | Contipro Biotech S.R.O. | Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití |
| CA2838059C (en) * | 2011-06-03 | 2020-08-25 | Maguire Abbey, Llc | Method, composition, and articles for improving joint lubrication |
| WO2012171335A1 (en) * | 2011-06-16 | 2012-12-20 | The Hong Kong University Of Science And Technology | Multi-vinylsulfone containing molecule |
| TWI561535B (en) | 2011-10-06 | 2016-12-11 | Bvw Holding Ag | Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption |
| US20130108550A1 (en) | 2011-10-26 | 2013-05-02 | Abbott Cardiovasculr Systems, Inc. | Bioabsorbable Co-Filler for Cerebrovascular Aneurysms |
| WO2013078770A1 (en) * | 2011-12-02 | 2013-06-06 | The Hong Kong University Of Science And Technology | Injectable gelling material |
| CZ303879B6 (cs) | 2012-02-28 | 2013-06-05 | Contipro Biotech S.R.O. | Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití |
| CZ304512B6 (cs) | 2012-08-08 | 2014-06-11 | Contipro Biotech S.R.O. | Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití |
| CZ304654B6 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
| HK1214618A1 (zh) | 2013-01-11 | 2016-07-29 | Carbylan Therapeutics, Inc. | 含有透明質酸的穩定化組合物 |
| JP6215354B2 (ja) * | 2013-01-23 | 2017-10-18 | セムヌール ファーマシューティカルズ, インコーポレイテッド | 不溶性コルチコステロイドおよび可溶性コルチコステロイドを含む医薬処方物 |
| JP6781220B2 (ja) * | 2013-02-04 | 2020-11-04 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | 基板用コーティング |
| RU2698315C2 (ru) * | 2013-02-04 | 2019-08-26 | В.Л. Гор Энд Ассошиейтс, Инк. | Покрытие для подложки |
| US9511119B2 (en) * | 2013-03-15 | 2016-12-06 | NuTech Spine, Inc. | Preparations containing hepatocyte growth factor and hyaluronic acid and methods of making and using same |
| US9844597B2 (en) | 2013-04-18 | 2017-12-19 | The Hong Kong University Of Science And Technology | Biocompatible in situ hydrogel |
| RU2640865C2 (ru) * | 2013-06-28 | 2018-01-12 | Гальдерма С.А. | Способ производства формованного продукта из поперечно-сшитой гиалуроновой кислоты |
| WO2015053282A1 (ja) * | 2013-10-08 | 2015-04-16 | キユーピー株式会社 | カルボキシメチル基含有修飾ヒアルロン酸および/またはその塩の架橋物およびその製造方法 |
| CN105658674B (zh) * | 2013-10-08 | 2019-04-09 | 丘比株式会社 | 含有羧甲基的修饰透明质酸和/或其盐和/或其制造方法 |
| WO2015053281A1 (ja) * | 2013-10-08 | 2015-04-16 | キユーピー株式会社 | カルボキシメチル基含有修飾ヒアルロン酸および/またはその塩の架橋物およびその製造方法 |
| WO2015134906A1 (en) * | 2014-03-07 | 2015-09-11 | Endologix, Inc. | Forming hydrogels and materials therefor |
| US9895394B2 (en) * | 2014-03-10 | 2018-02-20 | Kai-shun Christopher LEUNG | Induction of chronic elevation of intraocular pressure with vinysulfonated hyaluronic acid (HA-VS) and thiolated hyaluronic acid (HA-SH)hydrogel |
| CZ2014150A3 (cs) | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
| CZ2014451A3 (cs) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
| KR20170070008A (ko) | 2014-08-15 | 2017-06-21 | 더 존스 홉킨스 유니버시티 | 조직 복원용 복합 재료 |
| CZ309295B6 (cs) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití |
| CZ2015398A3 (cs) | 2015-06-15 | 2017-02-08 | Contipro A.S. | Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin |
| CZ306662B6 (cs) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití |
| EP3320028A1 (en) * | 2015-09-01 | 2018-05-16 | Merz Pharma GmbH & Co. KGaA | Method of making a cross-linked polymer gel and device for performing the method |
| WO2017042301A1 (en) * | 2015-09-09 | 2017-03-16 | ETH Zürich | Injectable macroporous hydrogels |
| CN108697804B (zh) * | 2015-10-05 | 2022-11-15 | 德克萨斯州立大学董事会 | 用于软骨损伤的检测和治疗的微米和纳米装置 |
| CN105606602A (zh) * | 2015-12-22 | 2016-05-25 | 上海景峰制药有限公司 | 一种测定交联透明质酸钠凝胶中二巯基聚乙二醇残留的方法 |
| TWI727014B (zh) * | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
| CZ308106B6 (cs) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití |
| KR20180027126A (ko) | 2016-09-06 | 2018-03-14 | (주)한국비엠아이 | 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물 |
| EP4253956A3 (en) * | 2016-10-14 | 2023-12-06 | Wake Forest University Health Sciences | Multi-organ "body on a chip" apparatus utilizing a common media |
| WO2018136205A1 (en) * | 2016-12-29 | 2018-07-26 | Tempo Therapeutics, Inc. | Methods and systems for treating a site of a medical implant |
| BR112019017795B1 (pt) | 2017-02-28 | 2022-12-06 | Cg Bio Co., Ltd. | Composição para injeção dérmica |
| EP3590546B1 (en) * | 2017-02-28 | 2024-08-21 | CG Bio Co., Ltd. | Composition for skin injection |
| WO2018159982A1 (ko) * | 2017-02-28 | 2018-09-07 | (주)시지바이오 | 피부 주입용 조성물 |
| US20180250225A1 (en) * | 2017-03-01 | 2018-09-06 | Church & Dwight Co., Inc. | Gummy composition with improved stability |
| EP3600442A1 (en) * | 2017-03-22 | 2020-02-05 | Genentech, Inc. | Optimized antibody compositions for treatment of ocular disorders |
| US11419941B2 (en) | 2017-05-30 | 2022-08-23 | Brenda K. Mann | Vaginal hydrogel |
| JP7854781B2 (ja) * | 2017-09-01 | 2026-05-07 | ピーエムアイディージー・エルエルシー | 官能基化および架橋ポリマー |
| US12029753B2 (en) | 2017-09-19 | 2024-07-09 | The Hong Kong University Of Science And Technology | Biocompatible material and methods for making and using thereof |
| US20190240335A1 (en) * | 2018-02-07 | 2019-08-08 | Promedon S.A. | Biocompatible Hydrogel Compositions |
| US10959945B2 (en) | 2018-03-21 | 2021-03-30 | Marina Lee Gerton | Vaginal hydrogel for delivery of therapeutics |
| EP3790602A1 (en) | 2018-05-09 | 2021-03-17 | The Johns Hopkins University | Nanofiber-hydrogel composites for cell and tissue delivery |
| ES3060255T3 (en) | 2018-05-09 | 2026-03-25 | Univ Johns Hopkins | Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration |
| CN112702992A (zh) * | 2018-07-20 | 2021-04-23 | 香港科技大学 | 用于靶试剂的受控释放的组合物和方法 |
| CN109045354B (zh) * | 2018-07-26 | 2020-12-08 | 华中科技大学 | 一种用于骨-软骨综合修复的原位成型可注射水凝胶 |
| EP3852725A4 (en) * | 2018-09-20 | 2022-08-03 | The Hong Kong University of Science and Technology | EYE DROP COMPOSITIONS |
| CN109223708B (zh) * | 2018-10-24 | 2021-07-20 | 上海景峰制药有限公司 | 一种交联玻璃酸钠的抗肿瘤药物组合物及其制备方法和应用 |
| EP3956367A1 (en) * | 2019-04-19 | 2022-02-23 | Jointherapeutics S.r.l. | Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states |
| KR102176486B1 (ko) * | 2019-06-14 | 2020-11-10 | 동국대학교 산학협력단 | 히알루론산 기반의 안과용 약물전달체의 제조방법 |
| CN111187429B (zh) * | 2019-06-18 | 2020-08-14 | 吾奇生物医疗科技(镇江)有限公司 | 双交联胶原水凝胶材料、其制备方法与应用 |
| WO2020264392A1 (en) * | 2019-06-26 | 2020-12-30 | Lacerta Technologies Inc. | Cross-linked hyaluronic acid hydrogels comprising proteins |
| CN110204746B (zh) * | 2019-06-28 | 2022-03-08 | 浙江科技学院 | 一种交联透明质酸钠凝胶的制备方法 |
| EP4090317A4 (en) * | 2020-01-16 | 2024-02-21 | The Hong Kong University of Science and Technology | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF A TARGET AGENT |
| JP2023522079A (ja) * | 2020-04-17 | 2023-05-26 | ブレンダン パトリック パーセル | ヒアルロン酸組成物の制御放出 |
| US20230173074A1 (en) * | 2020-04-23 | 2023-06-08 | Pleryon Therapeutics (Shenzhen) Limited | Biocompatible material and methods for making and using the same |
| WO2022120097A1 (en) * | 2020-12-03 | 2022-06-09 | Pmidg, Llc | Functionalized and crosslinked polymers |
| CN114276563B (zh) * | 2020-12-14 | 2023-02-24 | 南京工业大学 | 医用水凝胶的制备方法、水凝胶及敷料 |
| WO2022165416A1 (en) * | 2021-02-01 | 2022-08-04 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for making and using hybrid network hydrogels |
| KR102888000B1 (ko) * | 2021-10-25 | 2025-11-24 | 바이오플러스 주식회사 | 가교 히알루론산을 포함하는 가슴 보형물 및 이의 제조방법 |
| DE102021212812A1 (de) * | 2021-11-15 | 2023-05-17 | Bauerfeind Ag | Entzündungshemmendes viskosupplementierendes Mittel enthaltend Hyaluronsäure |
| ES2997963T3 (en) * | 2021-11-16 | 2025-02-18 | Pompadour Iberica S A | A beverage composition with controlled effervescence for infusion in a cold liquid |
| CN116919983A (zh) * | 2022-04-07 | 2023-10-24 | 北京瑞熙天成生物科技有限公司 | 一种用于治疗关节炎的基于官能化透明质酸或其钠盐的药物组合及其应用 |
| CN116919982A (zh) * | 2022-04-07 | 2023-10-24 | 北京瑞熙天成生物科技有限公司 | 一种用于治疗关节炎的药物组合物及其应用 |
| CN115364044B (zh) * | 2022-06-17 | 2024-07-09 | 浙江大学医学院附属第一医院 | 一种药物组合物及其制备方法和用途 |
| WO2024030437A1 (en) * | 2022-08-01 | 2024-02-08 | Pmidg, Llc | Functionalized and crosslinked polymer methods and compositions |
| KR20260009801A (ko) * | 2023-02-15 | 2026-01-20 | 라이프스프라웃, 인크. | 콜라겐-히드로겔 복합체 |
| CN121013705A (zh) * | 2023-02-15 | 2025-11-25 | 生命萌芽公司 | 改性的交联聚合物 |
| FI20245016A1 (en) * | 2024-01-11 | 2025-07-12 | Fysioline Oy | INJECTABLE COMPOSITION FOR CONTROLLED MEDICINE ADMINISTRATION |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128326A (en) | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| US4582865A (en) | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| DK130991D0 (da) | 1991-07-04 | 1991-07-04 | Immunodex K S | Polymere konjugater |
| WO1997022371A1 (en) | 1995-12-18 | 1997-06-26 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
| US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| PT939086E (pt) | 1998-02-27 | 2004-07-30 | Stichting Hippomedics | Processo para produzir o acido hialuronico reticulado |
| US6056970A (en) | 1998-05-07 | 2000-05-02 | Genzyme Corporation | Compositions comprising hemostatic compounds and bioabsorbable polymers |
| US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| US6521223B1 (en) * | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
| WO2002009792A1 (en) * | 2000-07-28 | 2002-02-07 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid |
| WO2002068383A2 (en) * | 2001-02-22 | 2002-09-06 | Anika Therapeutics, Inc. | Thiol-modified hyaluronan |
| WO2003096015A1 (en) | 2002-05-08 | 2003-11-20 | Matsushita Electric Industrial Co., Ltd. | Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| US7034127B2 (en) * | 2002-07-02 | 2006-04-25 | Genzyme Corporation | Hydrophilic biopolymer-drug conjugates, their preparation and use |
| US6802377B2 (en) | 2002-08-28 | 2004-10-12 | Mark S. Foltz | Hammer mounting apparatus |
| WO2004046200A1 (ja) | 2002-11-21 | 2004-06-03 | Chugai Seiyaku Kabushiki Kaisha | 薬物徐放担体 |
| US20050056608A1 (en) | 2003-09-15 | 2005-03-17 | Nesin Milton Scott | Bottle insert for storing and dispensing baby formula |
| US20050282747A1 (en) * | 2003-10-01 | 2005-12-22 | The Research Foundation Of State University Of New York At Stony Brook | Methods and compositions for wound healing |
| WO2005054301A1 (ja) | 2003-11-14 | 2005-06-16 | Chugai Seiyaku Kabushiki Kaisha | 架橋多糖微粒子およびその製造方法 |
| EP1694712A1 (en) | 2003-12-04 | 2006-08-30 | University of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
| KR20060130606A (ko) | 2003-12-12 | 2006-12-19 | 추가이 세이야쿠 가부시키가이샤 | 세포사 유도제 |
| BRPI0418309B8 (pt) * | 2003-12-30 | 2021-05-25 | Genzyme Corp | "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis". |
| US8524213B2 (en) | 2003-12-30 | 2013-09-03 | Genzyme Corporation | Polymeric materials, their preparation and use |
| WO2006028110A1 (ja) | 2004-09-07 | 2006-03-16 | Chugai Seiyaku Kabushiki Kaisha | 水溶性ヒアルロン酸修飾物の製造方法 |
| JP4875988B2 (ja) * | 2004-11-15 | 2012-02-15 | 株式会社 資生堂 | 架橋ヒアルロン酸ゲルの製造方法 |
| EP1817347B1 (en) | 2004-11-24 | 2017-05-17 | Albumedix A/S | Method of cross-linking hyaluronic acid with divinylsulfone |
| US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
| EP1994062B1 (en) | 2006-03-02 | 2009-07-15 | Novozymes Biopolymer A/S | Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| EP1871038B1 (en) | 2006-06-23 | 2010-06-02 | Nippon Office Automation Co., Ltd. | Network protocol and session analyser |
| WO2008008857A2 (en) | 2006-07-11 | 2008-01-17 | University Of Utah Research Foundation | Thiolated macromolecules and methods of making and using thereof |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | 巴克斯特國際公司 | 快速作用之乾密封膠及其使用和製造方法 |
| CN101200504B (zh) | 2006-12-11 | 2010-05-12 | 上海百瑞吉生物医药有限公司 | 高分子巯基化改性衍生物及其交联材料 |
| US20110077737A1 (en) | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
| US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
| BR112012002117A2 (pt) | 2009-07-30 | 2019-09-24 | Carbylan Biosurgery Inc | composições poliméricas modificadas de ácido hialurônico e métodos relacionados. |
| US8273725B2 (en) | 2009-09-10 | 2012-09-25 | Genzyme Corporation | Stable hyaluronan/steroid formulation |
-
2010
- 2010-07-23 BR BR112012002117A patent/BR112012002117A2/pt not_active IP Right Cessation
- 2010-07-23 AU AU2010276574A patent/AU2010276574B2/en not_active Ceased
- 2010-07-23 CN CN201080044014.3A patent/CN102573941B/zh not_active Expired - Fee Related
- 2010-07-23 US US12/842,762 patent/US7829118B1/en not_active Expired - Fee Related
- 2010-07-23 EP EP10738103A patent/EP2459239A1/en not_active Withdrawn
- 2010-07-23 RU RU2012107283/15A patent/RU2539395C2/ru not_active IP Right Cessation
- 2010-07-23 SG SG2012006227A patent/SG178146A1/en unknown
- 2010-07-23 US US13/387,682 patent/US8790702B2/en not_active Expired - Fee Related
- 2010-07-23 CA CA2769470A patent/CA2769470A1/en not_active Abandoned
- 2010-07-23 JP JP2012522921A patent/JP5683587B2/ja not_active Expired - Fee Related
- 2010-07-23 MX MX2012001204A patent/MX2012001204A/es active IP Right Grant
- 2010-07-23 KR KR1020127005345A patent/KR101551681B1/ko not_active Expired - Fee Related
- 2010-07-23 WO PCT/US2010/043108 patent/WO2011014432A1/en not_active Ceased
-
2012
- 2012-01-26 IL IL217750A patent/IL217750B/en not_active IP Right Cessation
- 2012-01-30 CL CL2012000243A patent/CL2012000243A1/es unknown
- 2012-01-30 ZA ZA2012/00727A patent/ZA201200727B/en unknown
-
2014
- 2014-07-16 US US14/333,426 patent/US9192678B2/en not_active Expired - Fee Related
-
2015
- 2015-10-30 US US14/929,115 patent/US9446136B2/en not_active Expired - Fee Related
-
2016
- 2016-09-13 US US15/264,550 patent/US9980977B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012107283A (ru) | Полимерные композиции модифицированной гиалуроновой кислоты и способы их применения | |
| JP6660469B2 (ja) | ヒアルロン酸誘導体およびdna分画物が含まれているヒアルロン酸注射用組成物およびその利用 | |
| US10207024B2 (en) | Biodegradable single-phase cohesive hydrogels | |
| JP6106686B2 (ja) | 水不溶性ゲル組成物およびその製造方法 | |
| ES2969063T3 (es) | Composiciones de polisacáridos reticulables in situ y usos de las mismas | |
| JP6063867B2 (ja) | ジスルフィド結合架橋生体適合性高分子ヒドロゲルおよびこれを含む製剤 | |
| JP6521862B2 (ja) | 皮膚用の注入可能な滅菌組成物 | |
| JP5155513B2 (ja) | ヒアルロン酸修飾物 | |
| TWI683674B (zh) | 具有改良抗性之多糖軟組織充填劑 | |
| Kaya et al. | Rheological properties of injectable hyaluronic acid hydrogels for soft tissue engineering applications | |
| JP6446462B2 (ja) | メピバカインを含有するヒアルロン酸組成物 | |
| US11707473B2 (en) | Method for the manufacture and use of a bionic hydrogel composition for medical applications | |
| ES2732317T3 (es) | Material de relleno dermocosmético y usos del mismo para fines estéticos | |
| JP2012505840A (ja) | インシトゥで架橋した注射用ヒドロゲルおよびその調製方法および用途 | |
| CN105682657A (zh) | 包含透明质酸和甲哌卡因的组合物 | |
| KR20160025026A (ko) | 가교된 히알루론산 생성물의 제조 방법 | |
| CN106714780A (zh) | 热凝胶组合物 | |
| CN105451786B (zh) | 交联的透明质酸、用于其制备的工艺及其在美学领域中的用途 | |
| US20170340774A1 (en) | Polethylene glycol hydrogel injection | |
| CN114514267A (zh) | 包含透明质酸和聚乙二醇的生物相容性水凝胶 | |
| CN107073167A (zh) | 灭菌的热凝胶组合物 | |
| US20220259388A1 (en) | Process for crosslinking a polymer | |
| KR102914224B1 (ko) | 아미드 가교결합된 하이드로겔의 가교결합-후 부분 분해 | |
| Bhatnagar et al. | Rheological characterization of novel HA-pluronic thermoreversible hydrogels | |
| HK40068702A (en) | Process for crosslinking a polymer |